The aim of the study is to assess the effect of short-term infusion of ketamine at analgesic
dosage on the immune response, morbidity and mortality among patients suffering from septic
shock. We hypothesize that ketamine will modulate the cytokine response to sepsis and reduce
morbidity and mortality.